论文部分内容阅读
全反式继甲酸（ATRA）明显提高急性早幼粒细胞白血病（APL）的完全缓解（CR）率已为国内外学者公认。目前临床普遍关注的是缓解后的长期生存问题。因此APL缓解后选择最佳的维持治疗方案则显得十分重要。为此我们对经地TRA达CR的22例APL患者用两种不同方案维持治疗，现将从1991?
ATRA significantly increased the complete remission (CR) rate of acute promyelocytic leukemia (APL) and was recognized by scholars at home and abroad. The current clinical concern is the long-term survival after remission. Therefore, it is very important to choose the best maintenance treatment after APL is relieved. To this end, we maintain the treatment of 22 patients with APL who have achieved CR in the TRA with two different regimens.